Health ❯Healthcare

Genetic Engineering

Genetic Engineering Clinical Trials Medical Research Oncology Cancer Treatment Biotechnology Patient Care Preventive Medicine Patient Outcomes Cholesterol Management

Universal CAR-T Therapy WU-CART-007 Achieves 72.7% Remission in T Cell Cancer Trial

Phase I/II results deliver a 91% overall response rate with mostly mild cytokine release syndrome alongside a larger international trial now underway

HSP-CAR30 Achieves Promising Results in Phase II Trial for Refractory Lymphomas

Breakthrough Cell Therapy IMA203 Achieves Durable Responses in Solid Tumors

Verve-102 Gene-Editing Therapy Shows Promising LDL Cholesterol Reduction in Early Trial